|
CASP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.26699794889396E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.71720448760971E-11 |
| Normal-vs-Stage2 |
2.241300E-03 |
| Normal-vs-Stage3 |
1.66510000010334E-07 |
| Normal-vs-Stage4 |
1.75369999966257E-07 |
| Stage1-vs-Stage2 |
1.035570E-01 |
| Stage1-vs-Stage3 |
5.522400E-01 |
| Stage1-vs-Stage4 |
7.792000E-01 |
| Stage2-vs-Stage3 |
2.954200E-01 |
| Stage2-vs-Stage4 |
2.104000E-01 |
| Stage3-vs-Stage4 |
8.219200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25219859323533E-11 |
| Normal-vs-AfricanAmerican |
3.537800E-03 |
| Normal-vs-Asian |
3.70799999593885E-08 |
| Caucasian-vs-AfricanAmerican |
8.175900E-02 |
| Caucasian-vs-Asian |
4.118800E-03 |
| AfricanAmerican-vs-Asian |
1.243690E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41979991599806E-10 |
| Normal-vs-Female |
2.14969997358594E-09 |
| Male-vs-Female |
9.506400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.642100E-04 |
| Normal-vs-Age(41-60Yrs) |
8.42126368638674E-12 |
| Normal-vs-Age(61-80Yrs) |
2.162000001249E-08 |
| Normal-vs-Age(81-100Yrs) |
3.799200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.269200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.263600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.623300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.502300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.724500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.757800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.54831999999994E-05 |
| Normal-vs-Grade 2 |
5.65836266730457E-12 |
| Normal-vs-Grade 3 |
1.00609999997836E-07 |
| Normal-vs-Grade 4 |
4.92090000003831E-06 |
| Grade 1-vs-Grade 2 |
4.451200E-01 |
| Grade 1-vs-Grade 3 |
8.387800E-02 |
| Grade 1-vs-Grade 4 |
2.579000E-01 |
| Grade 2-vs-Grade 3 |
1.637850E-02 |
| Grade 2-vs-Grade 4 |
3.483200E-01 |
| Grade 3-vs-Grade 4 |
4.512800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.16919807169324E-11 |
| Normal-vs-ccB subtype |
5.15620002250472E-09 |
| ccA subtype-vs-ccB subtype |
6.420600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.93630000921985E-10 |
| Normal-vs-N1 |
8.119400E-03 |
| N0-vs-N1 |
3.745400E-01 |
|
|
